Form 8-K - Current report:
SEC Accession No. 0001808665-25-000006
Filing Date
2025-03-12
Accepted
2025-03-12 16:05:17
Documents
15
Period of Report
2025-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asrt-20250312.htm   iXBRL 8-K 31528
2 EX-99.1 asrtq42024earningsreleasee.htm EX-99.1 381406
6 image0a06a.jpg GRAPHIC 3999
  Complete submission text file 0001808665-25-000006.txt   576288

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20250312.xsd EX-101.SCH 1863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20250312_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20250312_pre.xml EX-101.PRE 13121
17 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20250312_htm.xml XML 2825
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 25731729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)